India  

A drug under trial reduces risk of heart attack, stroke

IndiaTimes Wednesday, 2 April 2025
An experimental drug by Eli Lilly, called lepodisiran, has shown promising results in lowering Lp(a) levels, a particle linked to heart attack and stroke risk, by 94% with just one injection. While more studies are needed to confirm its effectiveness, this breakthrough could be significant for those with elevated Lp(a) levels, as existing treatments are limited.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Katie Price worried son Harvey is at risk of suffering a heart attack [Video]

Katie Price worried son Harvey is at risk of suffering a heart attack

Former glamour model Katie Price has admitted she's "heartbroken" over her son Harvey's weight issues and she's worried he's now at risk of suffering a heart attack.

Credit: Bang Showbiz     Duration: 01:14Published
Taking Proactive Steps Towards Heart Health [Video]

Taking Proactive Steps Towards Heart Health

Did you know that in a study of those who experienced a heart attack at age 50 or younger, half were not previously seen as high risk? Renowned cardiologist and Bayer spokesperson, Dr. Jayne Morgan,..

Credit: LifeMinute.tv     Duration: 02:30Published